Health

  • August 21, 2026

    75-Country Immigrant Visa Freeze Ruled 'Patently Unlawful'

    A New York federal judge on Friday struck down a U.S. Department of State policy that halted the issuance of visas to immigrants from 75 countries, finding the policy "patently unlawful" and in excess of Secretary of State Marco Rubio's statutory authority.

  • August 21, 2026

    Cytek Hit With $56M Verdict For Infringing Cell-Sorting Patent

    A Delaware federal jury Friday awarded roughly $36 million in damages to biomedical testing manufacturer Beckman Coulter after finding that Cytek Biosciences infringed one of its patents covering a technology that quickly analyzes single cells.

  • August 21, 2026

    Albertsons Twists Record In Opioid Trial Motion, Wash. Says

    Washington state is urging a Seattle judge to reject Albertsons' latest dismissal bid in a suit accusing the grocery giant of fueling the state's opioid epidemic, arguing the motion rehashes failed arguments and distorts evidence presented over the past five weeks in an ongoing bench trial.

  • August 21, 2026

    Trump Seeks Justices' Review Of DEI Grant Termination Case

    The Trump administration is urging the U.S. Supreme Court to review a Ninth Circuit decision requiring the federal government to reinstate research grants that were terminated due to presidential orders against diversity, equity and inclusion initiatives.

  • August 21, 2026

    Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award

    A New York federal court confirmed an arbitrator's finding that Sun Pharmaceuticals breached an agreement with the owner of an acne drug by seeking regulatory approval to market a version of the drug in Canada, rejecting arguments that the arbitrator wrongly relied on extrinsic evidence.

  • August 21, 2026

    Hogan Lovells Helps Advance Gene Therapy For Rare Disease

    Hogan Lovells Cadwalader partner Blake Wilson found himself scrolling through LinkedIn one day, when a post caught his eye that would spark a multiyear pro bono effort and lead to a breakthrough treatment for a rare and fatal disorder affecting children.

  • August 21, 2026

    Texas Senior Community Says Ch. 11 Plan Is Best It Can Offer

    Houston-based senior living community The Buckingham urged a Texas bankruptcy judge on Friday to confirm its Chapter 11 liquidation plan and overrule an objection by unsecured creditors, saying the deal offers the best possible recoveries and contains permissible legal releases.

  • August 21, 2026

    UC Health Pension Plan Defeats Doc's Denied Benefits Suit

    An Ohio federal judge tossed a doctor's suit claiming he was wrongfully denied pension benefits when UC Health bungled his years of qualifying service, ruling the calculations that concluded he was not eligible for payments were fair game under the plan's terms.

  • August 21, 2026

    NJ Medicaid Fee Law Barred By ERISA, Trade Groups Argue

    A coalition of restaurant, retail and hotel industry groups has urged a New Jersey federal court to strike down a state law requiring businesses to pay a fine when their employees are enrolled in the state Medicaid program, arguing the statute conflicts with federal benefits law.

  • August 21, 2026

    OhioHealth Faces Suit Over Insurance Contract Terms

    An Ohio health system has been hit with a proposed class action over its contractual restraints that a union health plan alleges prevent cheaper insurance providers from gaining a foothold in the market.

  • August 21, 2026

    Patients Drop Data Breach Suit Against Medical Billing Co.

    A group of patients has dropped a lawsuit accusing a Georgia-based medical billing practice of failing to properly secure the personal information of patients and employees ahead of a September data breach.

  • August 21, 2026

    Bio-Techne Gives FTC More Time On $11.3B Merck Deal

    Life science tool company Bio-Techne has withdrawn and refiled its intent to merge with pharmaceutical giant Merck in an $11.3 billion deal in order to give the Federal Trade Commission more time to scrutinize the deal for competition concerns.

  • August 21, 2026

    Radiology Co. Board Members Can't Dodge ESOP Trial

    A Colorado federal judge declined Friday to let board members of radiology company Envision escape a suit headed to a bench trial over claims they orchestrated an inflated $163.7 million stock sale to an employee stock ownership plan, ruling it's too contested whether they had control of the deal.

  • August 21, 2026

    ICE Contractor Wins Partial Block Of Colo. Inspection Law

    A Colorado federal judge temporarily blocked part of a new state law imposing additional inspections and penalties on The GEO Group Inc.'s immigration detention facility in Aurora, finding the provisions likely unlawfully discriminate against the company as a federal contractor.

  • August 21, 2026

    Pa. Hospital Worker Sues Over Unpaid Campus Walking Time

    Over 1,000 hourly workers at a University of Pittsburgh Medical Center facility have accused the employer of requiring them to badge in only upon reaching their workstations, leaving them uncompensated for time spent walking to and from their posts, according to a suit filed in state court.

  • August 20, 2026

    Uber Gets Greenlight On Most Fraud Claims Against LA Firms

    A California federal judge Wednesday largely rejected two Los Angeles personal injury firms' attempts to ditch Uber's suit claiming it's being targeted by a scheme involving fraudulent personal injury claims, finding Uber has plausibly alleged that the firms schemed with a surgeon to rack up medical costs.

  • August 20, 2026

    Elevance Health Gets Final OK On $14.75M Nurse OT Deal

    A Virginia federal court granted final approval Thursday to a $14.75 million global settlement resolving five related suits against Elevance Health by nurses who accused the insurer of misclassifying them as exempt from overtime pay.

  • August 20, 2026

    USPTO Tells Fed. Circ. 'Settled Expectations' Is Constitutional

    The U.S. Patent and Trademark Office has urged the Federal Circuit to reject Google's constitutional challenge to the office's "settled expectations" policy of taking the age of patents into account when deciding whether to review them, saying the rule is "eminently rational."

  • August 20, 2026

    Canadian Bioscience Cos. Settle 'Fake' Fuel Trading Suit

    A Colorado state judge agreed to issue a stay and administratively close a case brought by two Canadian bioscience companies alleging that a Denver resident defrauded them out of nearly $1 million through "fake" fuel trading deals, amid an undisclosed agreement reached between the parties.

  • August 20, 2026

    Colo. Panel Says Pretrial Meeting Didn't Affect Med Mal Trial

    A Colorado state appeals court on Thursday rejected a man's bid for a new trial in his medical malpractice lawsuit in which jurors sided with his physicians, finding the man did not show that an ex parte meeting between defense counsel and his own surgeon affected the trial's outcome.

  • August 20, 2026

    Judge Denies Bid To Move AT&T ERISA Case To State Court

    A California federal judge has denied a former AT&T employee's bid to move his class action suit alleging violations of state labor law over a tobacco surcharge on employee health plans from federal to state court.

  • August 20, 2026

    DOJ Pot Shift Changes LA Licensing Challenge, 9th Circ. Told

    A California attorney who has challenged state and local cannabis licensing policies across the country on the grounds that they discriminate against out-of-state entrants told the Ninth Circuit that recent federal shifts on medical marijuana mean the dormant commerce clause should apply to the once-federally illicit industry.

  • August 20, 2026

    Amgen Reaches Deal To End Ex-Worker's Tobacco Fee Fight

    Biotech giant Amgen Inc. struck a deal to end a proposed class action alleging a $150-a-month fee on the health plans of employees who used tobacco violated federal benefits law, according to a filing in California federal court Thursday.

  • August 20, 2026

    Johns Hopkins Hit With Sex Discrimination, Retaliation Suit

    Johns Hopkins University was hit with a complaint in California federal court alleging it impaired a graduate student's educational access and retaliated against her after she returned from a pregnancy-related leave and accused her former adviser of sexual misconduct.

  • August 20, 2026

    Sangamo Ch. 11 Auction Nets $238M In Offers

    A Delaware bankruptcy judge Thursday agreed to approve a trio of sales that will bring in $52 million in cash for Sangamo Therapeutics, after attorneys representing the life sciences group told the court a competitive Chapter 11 auction ended with four winning bids worth over $238 million.

Expert Analysis

  • Series

    Alpine Skiing Makes Me A Better Lawyer

    Author Photo

    Skiing has shaped habits I rely on daily as an attorney — focus, resilience and the ability to remain steady when circumstances shift rapidly — and influences the way I approach legal strategy, client counseling and teamwork, says Isaku Begert at Marshall Gerstein.

  • Weighing The Practical Implications Of SC Kids' Privacy Law

    Author Photo

    South Carolina's recently enacted Age-Appropriate Code Design Act includes a unique provision: a private right of action for certain violations, but its practical effect remains uncertain, as courts and litigants grapple with complex questions of standing, causation and the definition of actionable harm, say attorneys at K&L Gates.

  • FDA Guidance May Move Goalposts For Form 483 Responses

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration provides formal insight on how drug manufacturers are expected to respond to Form 483s, raising some concerns about the agency's timelines and expectations, say attorneys at Cooley.

  • 2 Strands Of Patent Law In High Court's 'Skinny Label' Case

    Author Photo

    Amarin v. Hikma, which is set for oral argument in the U.S. Supreme Court this month, highlights the distinction between two different strands of intellectual property law — analogizing a patent to either a property deed or a home, says Jonas McDavit at Spencer West.

  • Telehealth Suit May Redraw Rules For Physician Classification

    Author Photo

    A new class action in California federal court, Cioppettini v. Mochi Medical, alleging a telehealth company misclassified providers as independent contractors, suggests that traditional markers of physician independence may not apply to telehealth, say attorneys at Reed Smith.

  • Legal Theories In Social Media Verdicts Hold Clues On Impact

    Author Photo

    Although the two verdicts in cases in New Mexico and California involving Meta and Google are being lumped together, they rest on fundamentally different legal theories, and that distinction determines how their effects may be felt in other jurisdictions, says Mark Morgan at Day Pitney.

  • Senior Housing Demands A Distinct Dealmaking Playbook

    Author Photo

    An aging population and evolving state regulations underscore a critical reality that senior housing assets can undergo operational or compliance shifts during dealmaking, highlighting the need for unique contractual safeguards like expanded disclosures, anchored notice obligations, and targeted closing conditions and remedies, say attorneys at Goodwin.

  • Why MDLs Slow Down — And How To Speed Them Up

    Author Photo

    Multidistrict litigation has become central to mass tort practice, but as MDLs grow in size and complexity, so do delays and costs — so tools like the new federal rule governing MDLs, targeted use of special masters and strategically deployed Lone Pine orders are more essential than ever, say attorneys at Ice Miller.

  • A Check-Up On HHS' Push To Implement AI Infrastructure

    Author Photo

    The U.S. Department of Health and Human Services has made some headway in its efforts to implement artificial intelligence across its agencies, but will have to overcome a number of near-term tests in order to be successful, says Theodore Thompson at Stinson.

  • What A Court Doc Audit Reveals About Erroneous Filings

    Author Photo

    My audit of 1,522 court documents from last month found that over 95% contained at least one verifiable error, with fewer than 1% showing clear indicators of artificial intelligence use — highlighting above all else that lawyers may want to focus most on strengthening their review processes, says Elliott Ash at ETH Zurich.

  • Exploring When Fraud Asset Freezes Limit Right To Pick Atty

    Author Photo

    The defendant’s claim in the Seventh Circuit’s pending U.S. v. Shah case that the government restrained his assets until he couldn’t afford his chosen counsel presents a useful case study in how criminal forfeiture procedure interacts with U.S. Supreme Court rulings on Sixth Amendment rights and appealing complex fraud convictions, says Elisha Kobre at Sheppard.

  • Similar-Looking Designs May Not Always Prove Infringement

    Author Photo

    The Federal Circuit's recent decision in Range of Motion Products v. Armaid is a reminder that even a strikingly similar design might not be found to infringe upon a patented design once design features driven by functionality are filtered out from consideration, say attorneys at BCLP.

  • Series

    Mich. Banking Brief: All The Notable Legal Updates In Q1

    Author Photo

    Michigan's financial services sector saw several significant developments in 2026's first quarter, including the state Department of Insurance and Financial Services' issuance of a bulletin on the use of artificial intelligence and the Michigan House's introduction of a bill based on the Model Money Transmission Modernization Act, say attorneys at Dykema.

  • The Road Ahead For Drug Development In The US

    Author Photo

    Against the backdrop of drug manufacturers potentially looking to move development efforts overseas, the U.S. Food and Drug Administration's latest guidance on new approach methodologies signals the FDA is likely to be receptive to industry innovation that makes U.S.-based drug development faster or less expensive, creating opportunities and compliance risks for tech companies, say attorneys at Morgan Lewis.

  • FDA's Crackdown On Drug Ads Conflicts With Precedent

    Author Photo

    Recent U.S. Food and Drug Administration warning letters to drug manufacturers targeting direct-to-consumer advertising raise significant constitutional concerns, and directly clash with prior FDA stances, say attorneys at Sidley.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.